![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » VIOQUEST AGREES TO ACQUIRE GREENWICH
VIOQUEST AGREES TO ACQUIRE GREENWICH
July 8, 2005
VioQuest Pharmaceuticals, a biopharmaceutical company focused on acquiring, developing and commercializing novel compounds with broad therapeutic applications, entered into a definitive merger agreement to acquire Greenwich Therapeutics, which owns exclusive license rights to two anti-cancer agents -- sodium stibogluconate (SSG) and triciribine (TCN-P).
Pharmalive (http://www.medadnews.com/News/Index.cfm?articleid=254647)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct